Expanded Access for Repotrectinib

Sponsor
Bristol-Myers Squibb
Study ID
NCT05926232
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Repotrectinib for eligible participants.

Key Dates

Status verified
Jun 2023

Central Contacts

  • BMS Study Connect Contact Center http://www.bmsstudyconnect.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.